Effect of Vortioxetine on Cognitive Symptoms in Patients With Schizophrenia

Clinical trial NCT04456777 · UNKNOWN

Trial details

NCT number: NCT04456777
Sponsor: Alen Greš
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Cognitive Deficit

Start date: 2020-07-01
Primary completion: 2022-07-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.